The Hair Retention Protocol: Topical and Systemic Support Built in Evidence Order

Key Takeaways

A follicle that has miniaturised past a certain point does not come back, and androgenetic alopecia does not pause while a biotin gummy is given a fair trial. That makes the order of a hair-loss stack a cost question rather than a matter of taste: every month spent on the wrong layer is a month of progression the right layer would have slowed.

The common routine starts with a product that has "DHT" on the label, adds a biotin gummy, and waits. The evidence-ordered way starts by confirming what kind of hair loss this actually is, measuring the two nutrients that are worth measuring, and photographing the scalp so that six months from now there is something other than memory to judge by. Only then does it add a topical layer, then a systemic one — and it names, from the start, the prescription tier that outperforms all of it.

This is the evidence-ordered version. Its companion pages are the protocol itself, which carries the step-by-step schedule, and Hair Loss Science: DHT, Follicles and What Actually Works, which explains why the order is what it is. This article is the long-form guide: the layer table with grades, the diagnosis-first section, the photo method, the six-month schedule, how to run it alongside prescribed drugs, when to stop, and what is left out on purpose.

The Sentence That Has to Come First

Finasteride 1 mg and minoxidil 5% are the treatments with strong evidence for androgenetic alopecia, and the supplement layers below do not approach them.

In two one-year placebo-controlled trials of 1,553 men, with 1,215 continuing blinded into a second year, finasteride increased vertex hair count by 107 hairs at one year and 138 at two in a 5.1 cm² target against a baseline of 876 (P < 0.001), while placebo lost hair progressively. In 393 men over 48 weeks, minoxidil 5% was clearly superior to 2% and to placebo, with 45% more regrowth than 2%. Weekly microneedling added to minoxidil 5% produced a 91.4-hair gain per cm² versus 22.2 for minoxidil alone at 12 weeks; across 13 randomised trials, combination therapy added about 13.4 hairs/cm² over monotherapy with no increase in adverse events.

The protocol below is for the person with early, slow loss who wants to start with the lowest-risk layers, or for the person already on a prescription who wants to build honestly around it. It is not a way of avoiding the drugs for someone whose hair is coming out now. The follicles lost during a six-month supplement trial are not returned at the end of it.

The Layer Map

The protocol is graded C to its weakest load-bearing claim. Layer 3 is graded A and does not lend its grade to the layers beneath it.

Layer 0 — Diagnosis First, and Nothing Else Until It Is Done

Confirm the pattern

Androgenetic alopecia is gradual, symmetrical and patterned: temples and crown in men, a widening central parting with the frontal hairline preserved in women. The diagnostic feature is miniaturisation — thick terminal hairs replaced in the same spot by fine, short vellus ones. If a hand-mirror and a good light show that, this protocol applies.

If instead the loss is sudden, patchy, diffuse and by the handful, or accompanied by scalp pain, burning, scaling or pustules, it is not this disease. Telogen effluvium (diffuse shedding three to four months after a trigger), alopecia areata (autoimmune, smooth patches) and the scarring alopecias each need a dermatologist, and the scarring ones need one urgently because what fibroses does not regrow. A DHT blocker taken for six months in any of those is six months of delay.

Women: assessment before anything

The multidisciplinary Androgen Excess and PCOS task force is explicit: in every woman with pattern loss, assessment for androgen excess is mandatory, and vitamin D, iron, zinc, thyroid hormones and prolactin are optional but recommended. Irregular cycles, hirsutism or acne alongside thinning point to an endocrine cause that no supplement addresses.

Ferritin deserves an honest sentence. Iron deficiency is common in women and worth correcting on its own merits — but the largest controlled comparison, 381 women with pattern loss or chronic effluvium against 76 controls, found it not more common in the hair-loss groups than in controls. Check it because it is common and fixable, not because it is proven to be the cause.

Test, then correct — never the other way round

Zinc. Hair-loss patients as a group run lower serum zinc than controls — 84.33 versus 97.94 µg/dl in 312 patients against 30 controls (P = 0.002) — but the excess of frank deficiency below 70 µg/dl was significant only in alopecia areata (OR 4.02) and telogen effluvium, not in pattern loss. Supplement 15–25 mg elemental zinc only against a low result, for 8–12 weeks, then retest and stop. Chronic zinc above 40 mg/day depletes copper — the mineral GHK-Cu carries — which is a reason not to take it blindly.

Vitamin D. Across 23 studies (3,374 patients, 7,296 controls), non-scarring alopecia patients had 25(OH)D about 7.3 ng/mL lower than controls and three-fold odds of deficiency (OR 3.11, 95% CI 2.29–4.22). In 50 men with premature pattern loss, mean 25(OH)D was 20.1 versus 29.3 ng/mL in controls (P ≤ 0.001). That is association; no trial has shown that correcting it regrows hair in androgenetic alopecia. Dose 2,000 IU to a target of 30–50 ng/mL if below 30, retest at 8–12 weeks, and take it because being replete is worth having — not because it is a hair treatment.

The photographic baseline

This is the most important instrument in the protocol and the one most people skip. Every hair-loss trial worth reading used standardised photography or a tattooed target area; a home protocol has only the first.

Hair count changes of 10–20% are invisible day to day and unmistakable in paired photographs six months apart. Without this, the six-month decision will be made by mood.

Layer 1 — Topical

Two agents, applied at different times of day so the water-based peptide and the oil are never mixed.

Rosemary oil, 3% in a carrier, evening. Dilute the essential oil to 3% in jojoba, argan or fractionated coconut oil — about 9 drops per 15 ml — and massage 1–2 ml into the thinning areas, leaving it at least 30 minutes or overnight. Patch-test a 2% dilution on the forearm for 48 hours before the first use. The evidence is one six-month trial of 50 versus 50 against minoxidil 2%: no change in either arm at three months, significant increases in both at six, no difference between them, less itching with rosemary. The comparator was 2% rather than the standard 5%, and there was no placebo arm, so "as good as minoxidil 2%" cannot be separated from "neither did much". That is the whole case, and the full dissection is in Rosemary Oil vs Minoxidil: What the 2015 Trial Actually Showed. Never neat; never ingested.

GHK-Cu, 0.1–0.5% solution, morning. One to two millilitres to the thinning areas on a clean dry scalp. The hair-specific human evidence is thin and worth stating accurately: the ex-vivo work showing stimulated elongation of human hair follicles and dermal papilla proliferation used a related copper tripeptide, AHK-Cu, rather than GHK-Cu itself, and there is no randomised hair-count trial of either. It is here as a plausible, well-tolerated topical layer with a far stronger skin literature than hair literature. What it is and has shown is in GHK-Cu for Skin and Hair; this protocol adds only a slot in the schedule.

Layer 2 — Systemic

Saw palmetto, 320 mg standardised liposterolic extract, once daily with a fat-containing meal.

The evidence is one two-year open-label comparison in 100 men: 38% improved on saw palmetto against 68% on finasteride 1 mg, with the saw palmetto response mostly at the vertex. A systematic review found five randomised trials and two cohorts of products containing saw palmetto (100–320 mg) with positive but unisolated results — most were multi-ingredient blends — and concluded that robust high-quality data are lacking. It inhibits the same enzyme finasteride does, more weakly, and carries no sexual side-effect signal in the alopecia literature.

Two rules. Stop it two weeks before any surgery and do not combine it with anticoagulants or antiplatelet drugs: severe intraoperative haemorrhage with a prolonged bleeding time that normalised after stopping the extract has been reported. And do not add it to prescribed finasteride — same target, weaker inhibitor, no trial, and it makes it impossible to tell what is working. Avoid in pregnancy. The profile is at Saw Palmetto.

The Six-Month Schedule

Weeks 0–2 — Baseline. Confirm the pattern. Bloods: serum zinc, 25(OH)D; ferritin and TSH for women and for any man with atypical features; androgen assessment for women. Baseline photographs, three angles. Patch-test rosemary. Start nothing else.

Weeks 2–4 — Layer 0 only. Begin zinc and/or vitamin D only if the results came back low. If both were normal, Layer 0 is complete and consists of the photographs.

Week 4 — Add Layer 1. GHK-Cu in the morning, rosemary oil in the evening. Establish the habit before adding anything oral.

Week 8 — Add Layer 2 if wanted. Saw palmetto 320 mg with a meal.

Week 12 — First checkpoint. Retest anything that was low and adjust. Photograph. Do not judge the hair yet — the rosemary trial saw nothing at three months in either arm, and the finasteride data were still improving at two years. Three months is where the placebo effect peaks and the real effect has barely begun.

Weeks 12–24 — Run it. Monthly photographs. Note shedding — a rising shed count suggests effluvium, not pattern loss, and is a reason to see someone.

Week 24 — The decision. Compare month-six photographs with baseline, side by side, in the same light.

• Stable or improved → continue; reassess at twelve months.
• Continued visible progression → the supplement route has had its fair run. Move to Layer 3 or a dermatologist. Do not extend.

Running It Alongside Prescribed Drugs

Many people will arrive at this protocol already on minoxidil or finasteride, or will be prescribed them at the six-month decision. The layers combine cleanly with two adjustments.

With topical minoxidil. It stays, at the dose and frequency prescribed. Rosemary oil is applied at a different time of day and is never mixed into the minoxidil solution. GHK-Cu likewise. Neither topical is a reason to reduce the drug.

With finasteride or dutasteride. Drop Layer 2. Saw palmetto inhibits the same enzyme the drug already inhibits more completely; adding it has no trial support, no plausible additive benefit, and muddies any attempt to attribute a response. Layers 0 and 1 continue unchanged.

With microneedling. Do not apply rosemary oil, or any essential oil, to a freshly needled scalp. Wait at least 24 hours, longer if the scalp is still red.

With oral minoxidil or spironolactone. These are physician-managed and dose-dependent in both benefit and harm; nothing in this protocol interacts with them, and nothing in it should be added without the prescriber knowing.

Doses for the prescription tier are not given here because they belong to a prescriber who has examined the scalp, taken a history, and can stop the drug if it needs stopping.

Exit Criteria — Decide Them at Week 0

Write these down before starting so that sunk cost does not make the decision later.

• Visible progression in the six-month photographs — escalate to Layer 3 or refer
• Rapid loss at any point — do not wait for month six
• Patchy, sudden or diffuse shedding — a different diagnosis; dermatologist
• Scalp pain, burning, scaling, pustules — possible scarring alopecia; dermatologist promptly
• In women: irregular cycles, hirsutism, acne alongside thinning — endocrine assessment
• Contact dermatitis from rosemary — stop it; the rest of the protocol continues

Meeting any of these is not the protocol failing. It is the protocol working as designed, by handing over to the tier that has the evidence.

What This Protocol Deliberately Excludes

Biotin megadoses. Of three studies of oral biotin for hair growth, the one with a double-blind placebo-controlled design found no difference from placebo. Biotin corrects biotin deficiency, which is rare. It is the best-selling hair supplement in the world and it has no place here.

"DHT blocker" blends with undisclosed doses. Proprietary formulas listing saw palmetto, pumpkin seed, nettle, beta-sitosterol and zinc under one milligram figure cannot be dosed, cannot be judged, and — where they contain zinc at unknown levels — can push copper down over months. If saw palmetto is worth taking, it is worth taking at a known 320 mg of a known extract.

Oral essential oils. Rosemary essential oil taken internally is listed among documented convulsant essential oils, on account of its 1,8-cineole and camphor content. There is no oral hair indication and no safe reason to swallow it. Topical, diluted, or not at all.

Anything sold on serum DHT. Pattern loss is a follicle-sensitivity disease, not a DHT-level disease. Products that promise to "lower DHT naturally" are addressing a number that was not the problem.

Hormonal manipulation. Testosterone, DHEA and other androgen-axis interventions belong to a different protocol with different risks — Hormonal Optimization — and are, if anything, working against this one.

For the skin-ageing layer that many people run alongside — collagen, topical peptides, photoprotection — see Skin Longevity; the two protocols coexist without conflict.

Frequently Asked Questions

Can I skip Layer 0 if I already know it is pattern loss?

The photographs, no — they are the only instrument that will tell you at month six whether anything changed. The bloods, only if you are certain you are not deficient, which most people are not certain of. Layer 0 takes two weeks and costs less than a month of any supplement.

Why is saw palmetto in Layer 2 rather than first, if it is the DHT blocker?

Because it is the weaker inhibitor of the same enzyme finasteride inhibits, its one long comparison put it at roughly half the response rate, and it has a bleeding interaction. Topicals are lower-risk and go first. If the goal is 5-alpha-reductase inhibition, the drug does it properly and the supplement does it partially.

What if I am already on minoxidil and want to add this?

Keep the minoxidil exactly as prescribed. Add Layer 0 in full, Layer 1 at different times of day from the minoxidil, and Layer 2 if you are not on a 5-alpha-reductase inhibitor. Nothing here replaces the drug.

How is six months enough if finasteride took two years to show its full effect?

Six months is not the point at which a treatment has finished working; it is the earliest point at which standardised photographs can distinguish progression from stability. Continued visible loss at six months means the supplement layers are not holding the line and the decision should escalate. Stability at six months means continue and reassess at twelve.

Is this protocol suitable for women?

Layers 0 through 2 are, with the assessment step for androgen excess, ferritin and thyroid done first and taken seriously. The prescription tier differs: in women, minoxidil is first-line and finasteride 1 mg was no better than placebo in Cochrane's pooled data; spironolactone and other antiandrogens are physician territory.

What does "judged to its weakest claim" mean for this protocol?

That the grade of C belongs to the supplement layers, and that the person following it should expect a modest effect at best — stabilisation rather than regrowth in early, slow loss. The tier with a grade of A is the one the protocol hands over to when that is not enough.

Related Research

• The Hair Retention Protocol
• Hair Loss Science: DHT, Follicles and What Actually Works
• Rosemary Oil vs Minoxidil: What the 2015 Trial Actually Showed
• GHK-Cu for Skin and Hair
• Skin Longevity Protocol